The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
Like if you cut your skin, another tissue or organ in this case, that is the end of the skin
Crush injury models tend to show clearer BPC-157 effects than partial denervation models, which is consistent with the angiogenic-restoration mechanism: BPC-157 helps where revascularization is the limiting step in repair
So what is the current status of BPC 157
My job is to get you there safely, legally, and effectively , using tools that are proven, available, and tailored to bulldogs
HUBERMAN: Again, that's levels